Search for: "Johnson v. Abbott Laboratories Inc"
Results 41 - 60
of 68
Sort by Relevance
|
Sort by Date
19 Aug 2010, 3:00 am
Abbott Laboratories (E.D. [read post]
30 Jul 2010, 4:06 am
Alpharma, Inc. [read post]
24 Jun 2010, 5:00 am
Abbott Laboratories, 100 F.R.D. 336 (D. [read post]
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
13 May 2010, 12:27 pm
Abbott Laboratories, 2009 WL 2231701 (S.D.N.Y. [read post]
6 May 2010, 4:12 pm
Abbott Laboratories, 397 F. [read post]
7 Apr 2010, 3:44 pm
Click Here EPA Settles with Drug and Laboratory Disposal on Hazardous Waste Violations. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/19: Abbott Laboratories and Wisconsin Alumni Research Foundation v. [read post]
17 Sep 2009, 4:30 am
See Johnson v. [read post]
5 Jul 2009, 2:23 pm
After a reported five hours of deliberation, the jury in Centocor Inc v Abbott Laboratories awarded the Johnson & Johnson unit $1.67 billion for Abbott's willful infringement. [read post]
15 Apr 2009, 4:44 am
Friends for All Children, Inc. v. [read post]
9 Dec 2008, 7:03 am
The company has a wide variety of clients, including IBM, Genereal Electric, Motorola, Abbott Laboratories, and Eastman Koday. [read post]
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
3 Jul 2008, 7:26 pm
Abbott Laboratories, 568 F. [read post]
25 Jun 2008, 6:52 pm
Abbott Laboratories v. [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
